AIM’s innovators join the January sell-off
- The AIM All Share ended January down 10% with pharma and tech stocks selling off especially heavily
- The long-term outlook for these sectors continues to be positive
Predicting the end of easy money has been a pastime of doom-mongers’ for at least five years. January 2022 therefore provided ample opportunity for these pessimists to make sweeping statements as interest rate worries weighed heavily on growth stocks and share global indices crashed downwards. “We enter 2022 amid the most extreme financial bubble in US history,” said John Hussman, which will allow him to add 2022 to the list of market crashes he has…
Sign up and read the full article
Register to continue reading our content.
Already a member? Login
Previous article Next article